Clinical Trials Directory

Trials / Conditions / DS Stage II Plasma Cell Myeloma

DS Stage II Plasma Cell Myeloma

14 registered clinical trials studyying DS Stage II Plasma Cell Myeloma.

StatusTrialSponsorPhase
TerminatedDesipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoi
NCT01899326
Albert Einstein College of MedicineN/A
CompletedBortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multip
NCT01936090
Mayo ClinicPhase 1
CompletedCarfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma
NCT01842308
Mayo ClinicPhase 1 / Phase 2
UnknownNK Cells in Cord Blood Transplantation
NCT01619761
M.D. Anderson Cancer CenterPhase 1
Active Not RecruitingS1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly D
NCT01668719
SWOG Cancer Research NetworkPhase 1 / Phase 2
CompletedBusulfan, Melphalan, and Bortezomib Before First-Line Stem Cell Transplant in Treating Patients With Multiple
NCT01605032
Albert Einstein College of MedicinePhase 2
WithdrawnRO4929097 After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
NCT01251172
National Cancer Institute (NCI)Phase 2
CompletedVismodegib After Stem Cell Transplant in Treating Patients With High-Risk First Remission or Relapsed Multiple
NCT01330173
National Cancer Institute (NCI)Phase 1
TerminatedDonor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
NCT01028716
Fred Hutchinson Cancer CenterPhase 2
CompletedZoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple My
NCT00869206
Alliance for Clinical Trials in OncologyPhase 3
CompletedBortezomib and Vorinostat in Treating Patients With Multiple Myeloma Who Have Undergone Autologous Stem Cell T
NCT00839956
Fred Hutchinson Cancer CenterPhase 2
CompletedLenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant f
NCT00445692
Fred Hutchinson Cancer CenterPhase 2
CompletedBortezomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Previously Untreated Sy
NCT00088855
National Cancer Institute (NCI)Phase 2
CompletedFR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma
NCT00066638
National Cancer Institute (NCI)Phase 2